CeNeRx Raises $9 Million
CeNeRx BioPharma Inc., a Cary, N.C.-based developer of CNS drugs, has raised $4 million in Series C funding from return backers Aisling Capital, L Capital Partners and Pappas Ventures. It also secured a $5 million credit facility from MidCap Financial.
16 June 2009•4 mins read
